View Agent
| Agent Info | |
| Agent: | foretinib |
| Synonyms: | GSK 089;GSK 1363089;GSK1363089;XL 880;GSK1363089, GSK089, foretinib, EXEL-2880, XL880;88Z |
| Drug Status For Certain Diseases: | Solid tumours(phase I);Gastric cancer;Renal cell carcinoma;Squamous cell cancer of head and neck(phase II) |
| Classification: | an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR |
| Target: | Vascular endothelial growth factor receptor 2 Hepatocyte growth factor receptor |
| KEGG Pathway: | Ras signaling pathway Cytokine-cytokine receptor interaction Adherens junction Pathways in cancer Melanoma Bacterial invasion of epithelial cells Rap1 signaling pathway Epithelial cell signaling in Helicobacter pylori infection Transcriptional misregulation in cancer Proteoglycans in cancer Renal cell carcinoma Central carbon metabolism in cancer Axon guidance Focal adhesion VEGF signaling pathway MicroRNAs in cancer Endocytosis PI3K-Akt signaling pathway |
| Wiki Pathway: | miR-targeted genes in muscle cell - TarBase miR-targeted genes in squamous cell - TarBase Extracellular vesicle-mediated signaling in recipient cells TGF beta Signaling Pathway Angiogenesis Signaling Pathways in Glioblastoma miR-targeted genes in lymphocytes - TarBase Nifedipine Activity Signaling by VEGF Signaling of Hepatocyte Growth Factor Receptor Focal Adhesion miR-targeted genes in epithelium - TarBase Cardiac Progenitor Differentiation Semaphorin interactions |